Olfr885, a member of the olfactory receptor family, is integral to the detection and transduction of olfactory signals in the G-protein-coupled receptor (GPCR) framework. The activation of Olfr885 by specific odorants initiates a signaling cascade involving G proteins and various intracellular messengers, eventually leading to a neuronal response that translates into the perception of smell. These receptors are characterized by their high specificity and diversity, responding to a wide range of odorant molecules. Given the complexity and specificity of olfactory receptors like Olfr885, direct inhibition through specific binding is a significant challenge. Thus, indirect inhibition becomes a more viable approach, focusing on modulating the signaling pathways and cellular processes that influence the receptor's function. Indirect inhibitors, primarily targeting the beta-adrenergic system in this case, operate by altering intracellular signaling mechanisms, particularly the levels of cAMP, a key secondary messenger in GPCR signaling.
Beta-adrenergic antagonists, for instance, reduce cAMP levels within olfactory sensory neurons, which could indirectly impact the signaling cascade initiated by olfactory receptors like Olfr885. This reduction in cAMP levels leads to a decreased responsiveness of the GPCRs to their specific ligands. Additionally, the modulation of intracellular ion dynamics can also influence GPCR signaling, thereby indirectly affecting Olfr885's activity. It's important to note that these indirect methods of inhibition do not target Olfr885 specifically but rather influence broader signaling networks and cellular processes that, in turn, impact the receptor's function. This reflects the interconnected nature of GPCR signaling and the potential for pharmacological agents to modulate the function of olfactory receptors by targeting associated pathways. The inhibitors listed above represent a range of compounds that, through their action on various aspects of GPCR signaling, have the potential to indirectly influence the function of Olfr885.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol, a non-selective beta-adrenergic agonist, can indirectly inhibit Olfr885 by desensitization of beta-adrenergic receptors, leading to a reduction in cAMP levels. This reduction may subsequently impact GPCR signaling pathways, including those involving olfactory receptors. | ||||||
Nadolol | 42200-33-9 | sc-253175 | 1 g | $180.00 | ||
Nadolol, a non-selective beta-adrenergic antagonist, potentially inhibits Olfr885 by reducing intracellular cAMP levels in olfactory sensory neurons, impacting GPCR-mediated signaling. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $122.00 $235.00 $520.00 $979.00 $1500.00 | 2 | |
Carvedilol, a beta-adrenergic antagonist with alpha-blocking activity, may indirectly inhibit Olfr885 by modulating neurotransmitter dynamics and receptor responsiveness in the olfactory system. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol, a non-selective beta-adrenergic receptor antagonist, indirectly inhibits Olfr885 by reducing cAMP levels, crucial for GPCR activation and signaling in olfactory receptors. | ||||||
(RS)-Atenolol | 29122-68-7 | sc-204895 sc-204895A | 1 g 10 g | $77.00 $408.00 | 1 | |
Atenolol, a selective beta-1 adrenergic receptor antagonist, potentially inhibits Olfr885 indirectly by affecting cAMP levels in olfactory neurons, thus impacting GPCR-mediated signaling. | ||||||
Metoprolol Tartrate | 56392-17-7 | sc-205751 sc-205751A | 5 g 25 g | $105.00 $238.00 | 3 | |
Metoprolol, a selective beta-1 adrenergic receptor antagonist, can indirectly affect Olfr885 by modulating cAMP levels and influencing the GPCR signaling cascade in olfactory sensory neurons. | ||||||
Bisoprolol | 66722-44-9 | sc-278792 | 25 mg | $204.00 | ||
Bisoprolol, a selective beta-1 adrenergic receptor antagonist, may indirectly inhibit Olfr885 by impacting cAMP levels in olfactory neurons, influencing GPCR-mediated signaling processes. | ||||||
Nebivolol | 99200-09-6 | sc-279910 | 100 mg | $803.00 | 1 | |
Nebivolol, a beta-1 adrenergic receptor antagonist with vasodilatory effects, might indirectly inhibit Olfr885 by modulating GPCR signaling pathways through alterations in cAMP levels. | ||||||
Sotalol hydrochloride | 959-24-0 | sc-203699 sc-203699A | 10 mg 50 mg | $67.00 $246.00 | 3 | |
Sotalol, a non-selective beta-adrenergic antagonist and potassium channel blocker, could indirectly inhibit Olfr885 by altering intracellular ion dynamics and cAMP levels, affecting GPCR signaling. | ||||||
(S)-Timolol Maleate | 26921-17-5 | sc-203297 sc-203297A | 100 mg 250 mg | $60.00 $124.00 | ||
Timolol, a non-selective beta-adrenergic receptor antagonist, can indirectly inhibit Olfr885 by blocking beta-adrenergic receptors, reducing cAMP levels, and affecting GPCR-mediated responses. | ||||||